Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-directed DNA polymerase activity	POLE POLG POLD4 REV1	1.20e-05	25	115	4	GO:0003887
GeneOntologyMolecularFunction	interleukin-1, type II, blocking receptor activity	IL1RAPL2 IL1R2	3.29e-05	2	115	2	GO:0004910
GeneOntologyMolecularFunction	DNA polymerase activity	POLE POLG POLD4 REV1	6.62e-05	38	115	4	GO:0034061
GeneOntologyMolecularFunction	nucleotidyltransferase activity	POLE POLG POLR2B POLR3F POLD4 REV1	2.51e-04	152	115	6	GO:0016779
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	POLE POLG POLR2B DARS1 HELB POLR3F METTL1 POLD4 TRMT13 ENDOG NOP2 REV1	3.46e-04	645	115	12	GO:0140640
GeneOntologyMolecularFunction	single-stranded DNA 3'-5' DNA exonuclease activity	POLE POLG	4.86e-04	6	115	2	GO:0008310
MousePheno	abnormal hemoglobin	REC8 AMPD2 VWF KRT32 POLG CDH23 CCDC57 ITGB3 ZC3H7A SLC38A10 ADIPOR1 ARRB1 DNAJA4 ZNF641 CIAPIN1 MTMR3 RNF10 SLC4A10 DOCK6	2.25e-05	946	97	19	MP:0001588
Domain	IL-1_rcpt_II-typ	IL1RAPL2 IL1R2	3.56e-05	2	112	2	IPR004077
Domain	Rad21/Rec8_C_eu	REC8 RAD21	1.07e-04	3	112	2	IPR006909
Domain	Rad21_Rec8_N	REC8 RAD21	1.07e-04	3	112	2	IPR006910
Domain	Rad21_Rec8_N	REC8 RAD21	1.07e-04	3	112	2	PF04825
Domain	Rad21_Rec8	REC8 RAD21	1.07e-04	3	112	2	PF04824
Domain	Phe_ZIP	SH2B2 SH2B1	1.07e-04	3	112	2	PF08916
Domain	Phe_ZIP	SH2B2 SH2B1	1.07e-04	3	112	2	IPR015012
Domain	Rad21/Rec8_C	REC8 RAD21	1.07e-04	3	112	2	IPR023093
Domain	-	REC8 RAD21	1.07e-04	3	112	2	1.10.10.580
Domain	SH2B	SH2B2 SH2B1	1.07e-04	3	112	2	IPR030523
Domain	Anion_exchange	SLC4A2 SLC4A10	3.52e-04	5	112	2	IPR001717
Domain	DUF3398	DOCK7 DOCK6	5.26e-04	6	112	2	PF11878
Domain	DOCK_C/D_N	DOCK7 DOCK6	5.26e-04	6	112	2	IPR021816
Domain	ANION_EXCHANGER_2	SLC4A2 SLC4A10	7.34e-04	7	112	2	PS00220
Domain	ANION_EXCHANGER_1	SLC4A2 SLC4A10	7.34e-04	7	112	2	PS00219
Domain	-	SLC4A2 SLC4A10	1.25e-03	9	112	2	3.40.1100.10
Domain	Band3_cytoplasmic_dom	SLC4A2 SLC4A10	1.25e-03	9	112	2	IPR013769
Domain	Band_3_cyto	SLC4A2 SLC4A10	1.25e-03	9	112	2	PF07565
Domain	PTrfase/Anion_transptr	SLC4A2 SLC4A10	1.55e-03	10	112	2	IPR016152
Domain	HCO3_transpt_euk	SLC4A2 SLC4A10	1.55e-03	10	112	2	IPR003020
Domain	HCO3_cotransp	SLC4A2 SLC4A10	1.55e-03	10	112	2	PF00955
Domain	HCO3_transpt_C	SLC4A2 SLC4A10	1.55e-03	10	112	2	IPR011531
Domain	PDZ	FRMPD4 PPP1R9A PRX AHNAK PARD3	1.60e-03	141	112	5	PF00595
Domain	IL-1_rcpt_fam	IL1RAPL2 IL1R2	1.89e-03	11	112	2	IPR015621
Domain	DHR-1_domain	DOCK7 DOCK6	1.89e-03	11	112	2	IPR027007
Domain	DHR_2	DOCK7 DOCK6	1.89e-03	11	112	2	PS51651
Domain	DHR_1	DOCK7 DOCK6	1.89e-03	11	112	2	PS51650
Domain	DHR-2	DOCK7 DOCK6	1.89e-03	11	112	2	PF06920
Domain	DOCK	DOCK7 DOCK6	1.89e-03	11	112	2	IPR026791
Domain	DOCK_C	DOCK7 DOCK6	1.89e-03	11	112	2	IPR010703
Domain	DOCK-C2	DOCK7 DOCK6	1.89e-03	11	112	2	PF14429
Domain	DHR-2	DOCK7 DOCK6	1.89e-03	11	112	2	IPR027357
Domain	PDZ	FRMPD4 PPP1R9A PRX AHNAK PARD3	1.99e-03	148	112	5	SM00228
Domain	-	FRMPD4 PPP1R9A PRX AHNAK PARD3	2.10e-03	150	112	5	2.30.42.10
Domain	PDZ	FRMPD4 PPP1R9A PRX AHNAK PARD3	2.17e-03	151	112	5	PS50106
Domain	PDZ	FRMPD4 PPP1R9A PRX AHNAK PARD3	2.23e-03	152	112	5	IPR001478
Domain	Neurexin-like	CADM4 SDC1	3.09e-03	14	112	2	IPR003585
Domain	4.1m	CADM4 SDC1	3.09e-03	14	112	2	SM00294
Domain	FERM_domain	FRMPD4 KRIT1 JAK3	3.16e-03	49	112	3	IPR000299
Domain	FERM_1	FRMPD4 KRIT1 JAK3	3.35e-03	50	112	3	PS00660
Domain	FERM_2	FRMPD4 KRIT1 JAK3	3.35e-03	50	112	3	PS00661
Domain	FERM_3	FRMPD4 KRIT1 JAK3	3.35e-03	50	112	3	PS50057
Domain	Band_41_domain	FRMPD4 KRIT1 JAK3	3.35e-03	50	112	3	IPR019749
Domain	B41	FRMPD4 KRIT1 JAK3	3.35e-03	50	112	3	SM00295
Domain	-	METTL1 PRMT5 CIAPIN1 NOP2	5.91e-03	120	112	4	3.40.50.150
Pathway	REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS	POLE UBA7 POLD4 REV1	4.46e-05	32	88	4	M27538
Pathway	REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS	POLE UBA7 POLD4 REV1	4.46e-05	32	88	4	MM15260
Pathway	REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE	POLE UBA7 POLD4 REV1	9.87e-05	39	88	4	M26897
Pathway	REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE	POLE UBA7 POLD4 REV1	9.87e-05	39	88	4	MM14475
Pathway	REACTOME_DNA_DAMAGE_BYPASS	POLE UBA7 POLD4 REV1	2.24e-04	48	88	4	M27698
Pathway	REACTOME_DNA_DAMAGE_BYPASS	POLE UBA7 POLD4 REV1	2.24e-04	48	88	4	MM15432
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 EPPK1 POLE POLG CDC42BPB SH2B2 JAK3 CCDC88C GAS2L1 SCAF1 DIP2A SLC38A10 EIF4ENIF1 SSH1 RRS1 AHNAK MTMR3 SDF4 SH3BP5L DOCK6 ENDOG	1.06e-10	1105	116	21	35748872
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	POLE POLR2B AIP TRAPPC8 CDC42BPB SLC4A2 ITPR1 CHMP7 PASK ZC3H7A DIP2A DNAJA4 RRS1 SDF4 TTC13 PARD3 ENDOG NOP2 BAG6 IMMT PBXIP1 PML RAD21	6.86e-10	1487	116	23	33957083
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ABCA2 VWF POLG DARS1 AIP FMNL2 CDC42BPB SH2B1 KRIT1 DIP2A UBA7 EFNA1 ARRB1 SCG2 MTMR3 RNF10 N4BP2L2 IMMT PBXIP1 GPRASP2	9.36e-09	1285	116	20	35914814
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	AMPD2 PPP1R9A AIP CCDC88C EIF4ENIF1 ANAPC1 MTMR3 DOCK7 PARD3 DOCK6 RAD21	3.21e-07	446	116	11	24255178
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	AMPD2 VWF PPP1R9A DARS1 ITGB3 CDC42BPB AHNAK PBXIP1 PML	3.56e-06	360	116	9	33111431
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	POLE ZNF207 CCDC12 HELB SSH1 PRMT5 AHNAK BAG6 PML RAD21	4.12e-06	469	116	10	27634302
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	POLR2B AIP SLC4A2 ZC3H7A EIF4ENIF1 ANAPC1 RRS1 CIAPIN1 SUGP1 SDF4 SH3BP5L TTC13	6.55e-06	733	116	12	34672954
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	POLE POLG POLR2B AIP ITPR1 CHMP7 DIP2A EIF4ENIF1 RRS1 MTMR3 TTC13 MINDY4 ENDOG NOP2 BAG6 IMMT RAD21	9.78e-06	1496	116	17	32877691
Pubmed	Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane.	VWF ITGB3	1.10e-05	2	116	2	22134168
Pubmed	Differential role of SH2-B and APS in regulating energy and glucose homeostasis.	SH2B2 SH2B1	1.10e-05	2	116	2	16455776
Pubmed	Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans.	REC8 RAD21	1.10e-05	2	116	2	10207075
Pubmed	Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity.	VWF ITGB3	1.10e-05	2	116	2	18045606
Pubmed	α-Kleisin subunit of cohesin preserves the genome integrity of embryonic stem cells.	REC8 RAD21	1.10e-05	2	116	2	36571142
Pubmed	Analyses of mRNA expression patterns of cohesin subunits Rad21 and Rec8 in mice: germ cell-specific expression of rec8 mRNA in both male and female mice.	REC8 RAD21	1.10e-05	2	116	2	12130806
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	POLR2B AIP SSH1 RRS1 AHNAK RNF10 NOP2 BAG6 IMMT SPIN3	1.57e-05	547	116	10	37267103
Pubmed	A proteome-scale map of the SARS-CoV-2-human contactome.	KRT32 CCDC57 AHNAK N4BP2L2 PBXIP1 IL27RA	2.62e-05	173	116	6	36217029
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AMPD2 DNAH7 ITPKB CCDC88C PRMT5 AHNAK RNF10 DOCK7 SH3BP5L PARD3 DOCK6 PML	3.21e-05	861	116	12	36931259
Pubmed	Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.	VWF ITGB3	3.30e-05	3	116	2	19765213
Pubmed	Association of ITPKB, IL1R2 and COQ7 with Parkinson's disease in Taiwan.	ITPKB IL1R2	3.30e-05	3	116	2	34244037
Pubmed	Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.	SH2B1 JAK3	3.30e-05	3	116	2	15121872
Pubmed	Spindle assembly checkpoint of oocytes depends on a kinetochore structure determined by cohesin in meiosis I.	REC8 RAD21	3.30e-05	3	116	2	24291092
Pubmed	Platelets, inflammatory cells, von Willebrand factor, syndecan-1, fibrin, fibronectin, and bacteria co-localize in the liver thrombi of Bacillus anthracis-infected mice.	VWF SDC1	3.30e-05	3	116	2	22001909
Pubmed	Platelet adhesion receptors do not modulate infarct volume after a photochemically induced stroke in mice.	VWF ITGB3	3.30e-05	3	116	2	17996853
Pubmed	Self-regulated alternative splicing at the AHNAK locus.	PRX AHNAK	3.30e-05	3	116	2	21940993
Pubmed	Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.	VWF ITGB3	3.30e-05	3	116	2	30305279
Pubmed	SH2-B family members differentially regulate JAK family tyrosine kinases.	SH2B2 SH2B1	3.30e-05	3	116	2	11751854
Pubmed	Genomic characterization of the human type I cuticular hair keratin hHa2 and identification of an adjacent novel type I hair keratin gene hHa5.	KRT32 KRT35	3.30e-05	3	116	2	8823373
Pubmed	Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly.	SH2B2 SH2B1	3.30e-05	3	116	2	14766215
Pubmed	Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor.	VWF ITGB3	3.30e-05	3	116	2	7505120
Pubmed	Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress.	VWF ITGB3	3.30e-05	3	116	2	18927433
Pubmed	UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.	UBA7 PML	3.30e-05	3	116	2	11891284
Pubmed	Rec8-containing cohesin maintains bivalents without turnover during the growing phase of mouse oocytes.	REC8 RAD21	3.30e-05	3	116	2	20971813
Pubmed	The Commensal Microbiota Enhances ADP-Triggered Integrin αIIbβ3 Activation and von Willebrand Factor-Mediated Platelet Deposition to Type I Collagen.	VWF ITGB3	3.30e-05	3	116	2	32998468
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	POLE POLR2B AIP CCDC12 POLR3F ANAPC1 PRMT5 AHNAK CIAPIN1 POLD4 IMMT PML RAD21	3.51e-05	1014	116	13	32416067
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PPP1R9A POLR2B ZNF207 CDC42BPB SCAF1 ZC3H7A ARRB1 EIF4ENIF1 ANAPC1 RRS1 PRMT5 PARD3 IMMT SDC1 PBXIP1 RAD21	3.84e-05	1497	116	16	31527615
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPPK1 PPP1R9A POLR2B DARS1 BLMH SCAF1 RRS1 PRMT5 AHNAK DOCK7 NOP2 BAG6 IMMT	3.88e-05	1024	116	13	24711643
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	VWF CHST1 SCAF1 RNF10 SDF4 FBLIM1 RAD21	4.80e-05	283	116	7	18854154
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	CDC42BPB DOCK7 LRP6 N4BP2L2 NOP2 IMMT	6.22e-05	202	116	6	24639526
Pubmed	Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa.	VWF ITGB3	6.59e-05	4	116	2	18487513
Pubmed	Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.	SH2B2 SH2B1	6.59e-05	4	116	2	11827956
Pubmed	A SCL4A10 gene product maps selectively to the basolateral plasma membrane of choroid plexus epithelial cells.	SLC4A2 SLC4A10	6.59e-05	4	116	2	14592810
Pubmed	Intercellular calcium communication regulates platelet aggregation and thrombus growth.	VWF ITGB3	6.59e-05	4	116	2	12668663
Pubmed	The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.	VWF ITGB3	6.59e-05	4	116	2	33576766
Pubmed	Kinetics of visual pigment regeneration in excised mouse eyes and in mice with a targeted disruption of the gene encoding interphotoreceptor retinoid-binding protein or arrestin.	RBP3 ARRB1	6.59e-05	4	116	2	10508404
Pubmed	Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.	VWF ITGB3	6.59e-05	4	116	2	8918453
Pubmed	Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.	IL1RAPL2 IL1R2	6.59e-05	4	116	2	16596202
Pubmed	Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.	SH2B2 SH2B1	6.59e-05	4	116	2	24358267
Pubmed	Wapl releases Scc1-cohesin and regulates chromosome structure and segregation in mouse oocytes.	REC8 RAD21	6.59e-05	4	116	2	32328639
Pubmed	Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.	VWF ITGB3	6.59e-05	4	116	2	11071623
Pubmed	CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.	ITGB3 SCARB2	6.59e-05	4	116	2	12055214
Pubmed	PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARα.	PRMT5 PML	6.59e-05	4	116	2	35622143
Pubmed	Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.	SH2B2 SH2B1	6.59e-05	4	116	2	19293402
Pubmed	Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.	ITGB3 SDC1	6.59e-05	4	116	2	19255147
Pubmed	Role of Formyl Peptide Receptors and β-Arrestin-1 in suPAR Signal Transduction in Mouse Podocytes: Interactions with αVβ3-Integrin.	ITGB3 ARRB1	6.59e-05	4	116	2	38247863
Pubmed	Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.	LRP6 SDC1	6.59e-05	4	116	2	24392029
Pubmed	ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists.	VWF ITGB3	6.59e-05	4	116	2	17003372
Pubmed	The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells.	CFLAR PRMT5	6.59e-05	4	116	2	30736843
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	EPPK1 POLR2B ITPR1 BLMH RRS1 AHNAK NOP2 IMMT PML RAD21	6.88e-05	652	116	10	31180492
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 POLE ANAPC1 RRS1 PRMT5 AHNAK DOCK7 NOP2 IMMT RAD21	6.96e-05	653	116	10	22586326
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	EPPK1 FRMPD4 PPP1R9A POLR2B ZNF207 DARS1 ITPR1 BLMH PRMT5 AHNAK DOCK7 NOP2	8.13e-05	949	116	12	36574265
Pubmed	SRSF10 Plays a Role in Myoblast Differentiation and Glucose Production via Regulation of Alternative Splicing.	ZNF207 MTMR3 IMMT	8.89e-05	26	116	3	26586428
Pubmed	Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein.	SH2B2 SH2B1	1.10e-04	5	116	2	14612394
Pubmed	Activating mutations in human acute megakaryoblastic leukemia.	JAK3 PML	1.10e-04	5	116	2	18755984
Pubmed	β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein.	ARRB1 LRP6	1.10e-04	5	116	2	24265322
Pubmed	Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.	VWF ITGB3	1.10e-04	5	116	2	19036705
Pubmed	Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.	VWF ITGB3	1.10e-04	5	116	2	16824188
Pubmed	Kinase activation through dimerization by human SH2-B.	SH2B2 SH2B1	1.10e-04	5	116	2	15767667
Pubmed	Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.	ITGB3 SDC1	1.10e-04	5	116	2	27819680
Pubmed	The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity.	JAK3 PRMT5	1.10e-04	5	116	2	10531356
Pubmed	STAG2 and Rad21 mammalian mitotic cohesins are implicated in meiosis.	REC8 RAD21	1.10e-04	5	116	2	12034751
Pubmed	Inflammation induces hemorrhage in thrombocytopenia.	VWF ITGB3	1.10e-04	5	116	2	18256319
Pubmed	Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability.	SSH1 MTMR3	1.10e-04	5	116	2	20477815
Pubmed	Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.	AMPD2 PRX GAS2L1 ARRB1 AHNAK RNF10 PML	1.25e-04	330	116	7	21044950
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	CADM4 PPP1R9A FMNL2 CDC42BPB SLC4A2 BLMH DOCK7 PARD3 SDC1	1.28e-04	569	116	9	30639242
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	EPPK1 POLR2B CDH23 PRMT5 AHNAK BAG6	1.43e-04	235	116	6	30258100
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ABCA2 POLR2B ZNF207 DARS1 AIP LMOD2 BLMH PASK ANAPC1 PRMT5 MTMR3 NOP2 IMMT GPRASP2	1.48e-04	1335	116	14	29229926
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	EPPK1 POLG IMMT RAD21 REV1	1.52e-04	150	116	5	30154076
Pubmed	A Y2H-seq approach defines the human protein methyltransferase interactome.	POLR3F DIP2A PRMT5 ZNF641 RNF10 DOCK7 BAG6	1.56e-04	342	116	7	23455924
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	DARS1 CDC42BPB ZC3H7A EIF4ENIF1 ANAPC1 RRS1 AHNAK CIAPIN1 DOCK7 NOP2	1.62e-04	724	116	10	36232890
Pubmed	Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression.	VWF ITGB3	1.64e-04	6	116	2	19332769
Pubmed	β-arrestin-1 participates in thrombosis and regulates integrin aIIbβ3 signalling without affecting P2Y receptors desensitisation and function.	ITGB3 ARRB1	1.64e-04	6	116	2	22318609
Pubmed	The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase η Mediates Its Interaction with the C-terminal Domain of Rev1.	POLE REV1	1.64e-04	6	116	2	26903512
Pubmed	Regulation of insulin and type 1 insulin-like growth factor signaling and action by the Grb10/14 and SH2B1/B2 adaptor proteins.	SH2B2 SH2B1	1.64e-04	6	116	2	23190452
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	POLR2B DARS1 AHNAK DOCK7 IMMT	1.83e-04	156	116	5	32850835
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	GALNT10 ABCA2 AIP SLC4A2 ITPR1 OLFML2A PRMT5 SCARB2 CIAPIN1 LRP6 SDF4 TTC13 PBXIP1	1.91e-04	1201	116	13	35696571
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	KRT35 ZNF207 DARS1 AIP FMNL2 CDC42BPB SCAF1 RRS1 AHNAK DOCK7 SDF4 PARD3 NOP2 SDC1	1.95e-04	1371	116	14	36244648
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TUB KRIT1 ITPR1 PRMT5 PARD3 NOP2 IMMT RAD21	2.00e-04	475	116	8	31040226
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EPPK1 POLR2B DARS1 SCAF1 RRS1 PRMT5 PARD3	2.06e-04	358	116	7	32460013
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PPP1R9A POLR2B AIP FAM171B CDC42BPB ITPR1 BLMH SSH1 AHNAK MTMR3 LRP6 SDF4	2.06e-04	1049	116	12	27880917
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	REC8 AIP CCDC57 DNAJA4 ENDOG BAG6 GPRASP2	2.24e-04	363	116	7	25036637
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	POLR2B AIP PASK RRS1 NOP2 BAG6 GPRASP2	2.28e-04	364	116	7	24778252
Pubmed	Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating β-catenin.	BAG6 RAD21	2.29e-04	7	116	2	38043062
Pubmed	Cohesin Smc1beta determines meiotic chromatin axis loop organization.	REC8 RAD21	2.29e-04	7	116	2	18180366
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	POLE POLR2B ZNF207 DARS1 BLMH SCAF1 ANAPC1 RRS1 PRMT5 DOCK7 NOP2 BAG6 IMMT RAD21	2.89e-04	1425	116	14	30948266
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	POLR2B AIP CDC42BPB SSH1 RRS1 MTMR3 DOCK7 SDF4 FBLIM1 BAG6 IMMT	2.91e-04	931	116	11	27432908
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	VWF PPP1R9A RBP3 DARS1 FMNL2 CDC42BPB ITPKB GAS2L1 DIP2A PRMT5 DOCK7 SLC4A10 IMMT PBXIP1	3.01e-04	1431	116	14	37142655
Pubmed	CCM1 regulates vascular-lumen organization by inducing endothelial polarity.	KRIT1 PARD3	3.05e-04	8	116	2	20332120
Pubmed	PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo.	CFLAR PML	3.05e-04	8	116	2	21803845
Pubmed	Human DNA polymerase ε is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19.	POLE POLR2B	3.05e-04	8	116	2	27235625
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	ZNF207 DARS1 CDC42BPB ANAPC1 PRMT5 AHNAK DOCK7 SDF4 NOP2 PML	3.90e-04	809	116	10	32129710
Interaction	TOP3B interactions	ABCA2 EPPK1 POLE POLG PPP1R9A DARS1 CDC42BPB SH2B2 JAK3 CCDC88C GAS2L1 SCAF1 ZC3H7A DIP2A SLC38A10 EIF4ENIF1 SSH1 RRS1 PRMT5 AHNAK MTMR3 SDF4 SH3BP5L DOCK6 ENDOG NOP2 IMMT	5.23e-08	1470	116	27	int:TOP3B
GeneFamily	DNA polymerases	POLE POLG POLD4 REV1	2.81e-06	23	79	4	535
GeneFamily	Cohesin complex	REC8 RAD21	5.19e-04	8	79	2	1060
GeneFamily	PDZ domain containing	FRMPD4 PPP1R9A PRX AHNAK PARD3	5.37e-04	152	79	5	1220
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1RAPL2 IL1R2 IL27RA	8.15e-04	42	79	3	602
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	FLVCR2 CCDC12 RRS1 PRMT5 ZNF641 CIAPIN1 ENDOG NOP2	3.14e-06	200	116	8	M4262
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MUC15 DNAH7 CFAP65 DNAJA4 KIF19 AGBL2 CFAP46	8.26e-07	194	117	7	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITPKB CHMP7 PASK AHNAK SCARB2 KIF17	5.32e-06	167	117	6	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH7 CFAP65 CCDC88C KIF19 AGBL2 CFAP46	5.69e-06	169	117	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF LAMP5 NPDC1 CDC42BPB UBA7 MAMSTR	6.30e-06	172	117	6	8a6a2b4c6654bc976e60a02d0e7303a9071ed55f
ToppCell	droplet-Marrow-nan-21m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH2B2 METTL1 RRS1 PRMT5 ENDOG NOP2	1.05e-05	188	117	6	f94dc08948a823f47882aa0714b9a60de4ff85d5
ToppCell	droplet-Marrow-nan-21m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH2B2 METTL1 RRS1 PRMT5 ENDOG NOP2	1.05e-05	188	117	6	7c67330c36696a7772364af67c6df4e6406fa742
ToppCell	moderate-Lymphoid-Treg\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GALNT10 JAK3 SLC4A10 N4BP2L2 PBXIP1 IL27RA	1.18e-05	192	117	6	e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWF CDH23 NPDC1 OLFML2A AHNAK TNXB	1.21e-05	193	117	6	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EPPK1 VWF NPDC1 PRX EFNA1 DOCK6	1.36e-05	197	117	6	a312d9cf4ced949307eb9620be4eed926300b892
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF NPDC1 PRX CFLAR SSH1 PML	1.49e-05	200	117	6	24fa22fb93c4533a79e5d95d241a60f4b13e5631
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	ZNF207 ITPR1 HELB JAK3 N4BP2L2	6.89e-05	162	117	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMOD2 ARRB1 IL1R2 SCG2 ZNF641	7.73e-05	166	117	5	ec7bd549bda5f18aca8aebce5ba479a81abbbeda
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC8 VWF IL1RAPL2 PARD3 DOCK6	8.18e-05	168	117	5	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	ASK440-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	CFAP65 KIF19 PARD3 SDC1 PBXIP1	8.18e-05	168	117	5	127559d1a083c68cda9fce143afcc3eec168df17
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REC8 VWF IL1RAPL2 PARD3 DOCK6	8.18e-05	168	117	5	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF DOCK7 MAMSTR FBLIM1 DOCK6	8.41e-05	169	117	5	780fb0050852626062a729dd1b82b0cf61e7e9ca
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF FAM171B TRAPPC8 HELB ARRB1	9.13e-05	172	117	5	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF CDH23 ITGB3 GAS2L1 UBA7	1.05e-04	177	117	5	84591e28482ab62a5ef41e61043eb64912766356
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF CDH23 ITGB3 GAS2L1 UBA7	1.05e-04	177	117	5	4bc100062891d07cacd10ffba38966cc6302c92f
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF CDH23 ITGB3 GAS2L1 UBA7	1.05e-04	177	117	5	9f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4\|GI_large-bowel / Manually curated celltypes from each tissue	EPPK1 CADM4 ITPKB EFNA1 CIAPIN1	1.05e-04	177	117	5	eb87ea93e36a8f97442ec8515f658ee61932dc0f
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 TUB KIF19 AGBL2 CFAP46	1.07e-04	178	117	5	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HELB JAK3 PASK DNAJA4 PBXIP1	1.10e-04	179	117	5	02218c048e4dec0c0a3d63d2abb4feb4c3e82697
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CABP7 MUC15 CFAP65 SCG2 KIF19	1.13e-04	180	117	5	d553aba594f5304f1c09ff9c6d49b64cd7ee7850
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPPK1 DNAH7 DNAJA4 KIF19 CFAP46	1.13e-04	180	117	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRMPD4 CHST1 TUB OLFML2A FBLIM1	1.16e-04	181	117	5	47dce04db3392333eb2f7b9b24c32e6740d2d02f
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRMPD4 CHST1 TUB OLFML2A FBLIM1	1.16e-04	181	117	5	19103221c3a5a16b16378348004b2c50caee4f01
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	VWF PPP1R9A NPDC1 CCDC88C EFNA1	1.25e-04	184	117	5	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CABP7 MUC15 CFAP65 SCG2 KIF19	1.29e-04	185	117	5	2088e82e0febdcf05618d3db913d00e2e87812f4
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.29e-04	185	117	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 DNAJA4 KIF19 AGBL2 CFAP46	1.29e-04	185	117	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	normal_Lung-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	CFLAR IL1R2 RRS1 PBXIP1 SPIN3	1.29e-04	185	117	5	ea416362d3f06b4a0a7f08c2e5dbbc864f121555
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	VWF NPDC1 EFNA1 FBLIM1 DOCK6	1.32e-04	186	117	5	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	VWF NPDC1 CHST1 PRX DOCK6	1.32e-04	186	117	5	f0b78c7ee20279970ea8961bf59acb5262f2dce5
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITPKB EFNA1 AHNAK DOCK6	1.32e-04	186	117	5	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	mild-unassigned\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LMOD2 PASK IL1R2 RRS1 KIF19	1.32e-04	186	117	5	5b2e1a58916f392fa1156bf9210df528775248ff
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|356C / Donor, Lineage, Cell class and subclass (all cells)	VWF NPDC1 CHST1 PRX DOCK6	1.32e-04	186	117	5	2b3c814a7dee8286ea113c63dc3de5daf0257d37
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	VWF NPDC1 KIF19 MINDY4 KIF17	1.35e-04	187	117	5	2713f526f86911fbbf6c7a3e69230f2e6bde31c3
ToppCell	Multiple_Sclerosis-Other\|Multiple_Sclerosis / Disease, Lineage and Cell Type	ITGB3 GAS2L1 ADIPOR1 RNF10 PARD3	1.35e-04	187	117	5	ca6f53e841fd016804e6e8ccf0199877b0e5cbdd
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.39e-04	188	117	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	VWF NPDC1 CHST1 CCDC88C EFNA1	1.39e-04	188	117	5	b66f1f08827dd6c48583d871f9f33ea41e48bfb2
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.39e-04	188	117	5	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF PPP1R9A PRX SSH1 KIF19	1.39e-04	188	117	5	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITPKB HELB JAK3 CCDC88C PBXIP1	1.42e-04	189	117	5	df30478b288084a1bd48f660409dcc784040897c
ToppCell	droplet-Marrow-BM-1m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METTL1 RRS1 PRMT5 ENDOG NOP2	1.42e-04	189	117	5	b81540e097e95158851e07bfd78640ed6e64c2cf
ToppCell	droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METTL1 RRS1 PRMT5 ENDOG NOP2	1.42e-04	189	117	5	0fda1a3f1e87fadf5309c8267beaa4501983b1dd
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF NPDC1 CCDC88C EFNA1 KIF17	1.42e-04	189	117	5	9e58411e51019ca59e78d3e737d65d2bcbbea2be
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF NPDC1 CCDC88C EFNA1 KIF17	1.42e-04	189	117	5	a34f008dfcee4012977bbc5b60de6f0329ca2f65
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NPDC1 JAK3 PASK ZC3H7A PBXIP1	1.46e-04	190	117	5	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITPKB HELB JAK3 CCDC88C PASK	1.46e-04	190	117	5	2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9
ToppCell	wk_08-11-Epithelial-PNS-Early_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CADM4 CDC42BPB OLFML2A ZNF641 SH3BP5L	1.46e-04	190	117	5	8190674a48607984726974765aafbca116f437e0
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.46e-04	190	117	5	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	VWF NPDC1 CHST1 CCDC88C EFNA1	1.46e-04	190	117	5	7ba2be2630183df86de21689289a8620a4cd507e
ToppCell	Adult-Immune-T_lymphocyte-D175\|Adult / Lineage, Cell type, age group and donor	ITPKB HELB JAK3 CCDC88C PBXIP1	1.49e-04	191	117	5	0b84fd1dc68146d9f72422b102744d2847f5ecb2
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	MUC15 DNAH7 CFAP65 KIF19 CFAP46	1.49e-04	191	117	5	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF CDH23 NPDC1 ITPKB DOCK6	1.49e-04	191	117	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MUC15 DNAH7 CFAP65 KIF19 CFAP46	1.49e-04	191	117	5	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NPDC1 CCDC88C AHNAK SLC4A10 PBXIP1	1.49e-04	191	117	5	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	MUC15 DNAH7 CFAP65 KIF19 CFAP46	1.49e-04	191	117	5	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	NS-moderate-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	JAK3 SLC4A10 N4BP2L2 PBXIP1 IL27RA	1.53e-04	192	117	5	48d557071bad80edd3ec6e5ad8dcd97037da9553
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	AIP ITPKB HELB JAK3 N4BP2L2	1.53e-04	192	117	5	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.53e-04	192	117	5	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITPKB HELB JAK3 CCDC88C PASK	1.53e-04	192	117	5	69a2b04f03a1b82d067018379f7b8a116e954040
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.53e-04	192	117	5	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	VWF CDH23 NPDC1 ITPKB DOCK6	1.53e-04	192	117	5	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF NPDC1 CHST1 EFNA1 DOCK6	1.53e-04	192	117	5	1f35efb0765e05f7f9c881849953bef3965be25a
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 ITGB3 AHNAK FBLIM1 TNXB	1.53e-04	192	117	5	a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.57e-04	193	117	5	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.57e-04	193	117	5	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	B_cell_maturation-plasma\|B_cell_maturation / Lineage and Cell class	CFLAR SLC38A10 AHNAK KIF19 SDC1	1.57e-04	193	117	5	5415f7e54bc40aec3dbe27fd97f6e9be6db08a48
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 SH2B2 ARRB1 SSH1	1.57e-04	193	117	5	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	Healthy_donor-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	EPPK1 HELB CHMP7 PASK LRP6	1.60e-04	194	117	5	bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.60e-04	194	117	5	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.60e-04	194	117	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX ITPKB DOCK6	1.60e-04	194	117	5	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX SSH1 DOCK6	1.60e-04	194	117	5	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	mild_COVID-19-CD4+_Tcm\|mild_COVID-19 / disease group, cell group and cell class (v2)	NPDC1 ITPKB PASK RRS1 PBXIP1	1.60e-04	194	117	5	cf085813138a73878f9586059cd1d01d1a7ee748
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF NPDC1 PRX SSH1 DOCK6	1.60e-04	194	117	5	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	LAM-Endothelial\|LAM / Condition, Lineage and Cell class	VWF NPDC1 PRX OLFML2A TNXB	1.60e-04	194	117	5	1241e3e75414b619abc9431627619f5c194ec930
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF NPDC1 PRX GAS2L1 FBLIM1	1.64e-04	195	117	5	83da75d210ae9c2a94018d70cb9e833b37004c4e
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 FAM171B FMNL2 PRX OLFML2A	1.64e-04	195	117	5	cad21edd90bf3e2fefdf5773a59cb1a664a69ddd
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.64e-04	195	117	5	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH7 CFAP65 KIF19 AGBL2 CFAP46	1.64e-04	195	117	5	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	VWF NPDC1 PRX CCDC88C EFNA1	1.68e-04	196	117	5	2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA2 NPDC1 AIP JAK3 PBXIP1	1.68e-04	196	117	5	072e0e29be4639344ead4ea6ad521e3338f5f8af
ToppCell	Tracheal-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA2 CADM4 LAMP5 PRX OLFML2A	1.68e-04	196	117	5	b6226163d9fc93ecfff2115bb74408303a000490
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA2 CADM4 CHST1 FAM171B DIP2A	1.68e-04	196	117	5	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JAK3 CCDC88C PASK AHNAK PBXIP1	1.68e-04	196	117	5	26f626e4df364e458431a5eccae076d1bed94ed4
ToppCell	tumor_Lung-B_lymphocytes-MALT_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	CFLAR SLC38A10 KIF19 SDF4 SDC1	1.68e-04	196	117	5	1f63dba9d226e4a42d9bee7258580a1e547c0e92
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JAK3 CCDC88C PASK AHNAK PBXIP1	1.68e-04	196	117	5	578afe58962a24874b99b0407a647b12e972344b
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	VWF NPDC1 EFNA1 FBLIM1 DOCK6	1.72e-04	197	117	5	f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|tumor_Lung / Location, Cell class and cell subclass	VWF NPDC1 CHST1 PRX OLFML2A	1.72e-04	197	117	5	353b76ca3e2aa4b8f51396e7121c4baa114083a0
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF NPDC1 PRX OLFML2A KIF17	1.72e-04	197	117	5	947042f888335c0829d4d5daeb623973eadb3348
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	VWF NPDC1 PRX EFNA1 DOCK6	1.72e-04	197	117	5	797ea1c9f75f88b51fdfc17a2b27ed0199ae64c9
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	GALNT10 POLE ITPKB CFLAR AHNAK	1.76e-04	198	117	5	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NPDC1 CCDC57 JAK3 PASK PBXIP1	1.76e-04	198	117	5	8a7897d98f5296745d9005a7cd777f0a2f78000d
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	VWF NPDC1 EFNA1 FBLIM1 DOCK6	1.76e-04	198	117	5	122215d9288533ad03562cf777e846504863df9a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GALNT10 ABCA2 CCDC88C AHNAK KIF19	1.76e-04	198	117	5	a6b942fe850e287e1cb705684e29218072daf891
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4\|bone_marrow / Manually curated celltypes from each tissue	ITPKB HELB JAK3 PASK PBXIP1	1.76e-04	198	117	5	f2d85d7ca0e867d20ad4d2b1cbbfd91a066c1a03
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	VWF NPDC1 EFNA1 FBLIM1 DOCK6	1.76e-04	198	117	5	307dd09e6bc820a148f3000f18dae7aedba4be0b
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A	REC8 FLVCR2 OLFML2A GAS2L1 IL1R2 LRP6 PBXIP1 IL27RA	5.32e-06	187	116	8	2571_UP
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	PAPPA2 ABCA2 ARRB1 SUGP1 PARD3 ENDOG NOP2 SLC27A5	6.45e-06	192	116	8	6166_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	PEX26 CFLAR CCDC88C ARRB1 IL1RAPL2 SCARB2 SUGP1 PML	6.71e-06	193	116	8	3866_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	KRT32 POLG FLVCR2 PEX26 EIF4ENIF1 DNAJA4 LRP6 SLC27A5	7.23e-06	195	116	8	7048_UP
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	PAPPA2 CADM4 FLVCR2 ITGB3 CFLAR PASK ARRB1 PML	7.79e-06	197	116	8	4679_UP
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; HL60; HT_HG-U133A	REC8 PAPPA2 ABCA2 RBP3 CCDC57 DNAH7 DNAJA4 PML	8.09e-06	198	116	8	6129_UP
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	CADM4 CHST1 JAK3 PASK DNAJA4 SUGP1 PBXIP1 PML	8.09e-06	198	116	8	4316_UP
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; HL60; HG-U133A	ABCA2 POLG FLVCR2 PRX SUGP1 PARD3 PBXIP1 IL27RA	8.39e-06	199	116	8	1725_UP
Drug	PF-00356231	VWF SUGP1 BAG6 IMMT	1.58e-05	30	116	4	CID000448942
Drug	4-hydroxybenzyl alcohol	PRX BLMH IMMT	2.06e-05	11	116	3	CID000000125
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GALNT10 EPPK1 GAS2L1 AHNAK PARD3 DOCK6 IL27RA	4.62e-05	185	116	7	1049_DN
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	SH2B1 CCDC88C METTL1 ARRB1 ENDOG SLC27A5 PML	5.47e-05	190	116	7	6177_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ABCA2 SH2B1 CFLAR GAS2L1 IL1RAPL2 DOCK6 PBXIP1	5.65e-05	191	116	7	3815_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	KRIT1 ITPKB UBA7 ARRB1 SUGP1 PBXIP1 PML	5.84e-05	192	116	7	2271_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	ITPR1 CFLAR JAK3 PASK UBA7 SUGP1 PML	6.03e-05	193	116	7	997_UP
Drug	Kaempferol [520-18-3]; Down 200; 14uM; HL60; HT_HG-U133A	UBA7 ARRB1 PARD3 KIF17 PBXIP1 IL27RA PML	6.23e-05	194	116	7	6157_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	PEX26 ITPKB ITPR1 DNAJA4 LRP6 IL27RA PML	6.23e-05	194	116	7	2221_DN
Drug	Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	ABCA2 FLVCR2 GAS2L1 UBA7 ARRB1 IL1RAPL2 DOCK6	6.23e-05	194	116	7	4660_UP
Drug	Ethamivan [304-84-7]; Down 200; 18uM; HL60; HG-U133A	PAPPA2 CFLAR PASK AHNAK MTMR3 POLD4 RAD21	6.23e-05	194	116	7	1730_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	POLG PEX26 ITPKB CFLAR SUGP1 LRP6 PML	6.44e-05	195	116	7	2283_DN
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A	CCDC57 PASK IL1R2 SUGP1 LRP6 PBXIP1 PML	6.44e-05	195	116	7	2727_DN
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	PAPPA2 AMPD2 POLG PEX26 SUGP1 DOCK6 PML	6.65e-05	196	116	7	3272_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	FLVCR2 ITPR1 OLFML2A PASK SCARB2 LRP6 PML	6.65e-05	196	116	7	1642_UP
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A	ABCA2 CFLAR GAS2L1 SDC1 PBXIP1 IL27RA PML	6.65e-05	196	116	7	2943_UP
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	SH2B1 CFLAR UBA7 SUGP1 PARD3 DOCK6 PML	6.65e-05	196	116	7	2288_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A	PEX26 CFLAR CHMP7 OLFML2A SUGP1 LRP6 PARD3	6.87e-05	197	116	7	7287_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A	REC8 ABCA2 SH2B1 ITPKB LRP6 DOCK6 PML	6.87e-05	197	116	7	3039_DN
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A	PAPPA2 ABCA2 ITPKB OLFML2A SSH1 IL1R2 DOCK6	6.87e-05	197	116	7	3431_UP
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ABCA2 SLC4A2 CFLAR PASK SLC38A10 SUGP1 LRP6	6.87e-05	197	116	7	3415_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A	ABCA2 SH2B1 PEX26 CFLAR OLFML2A PBXIP1 PML	6.87e-05	197	116	7	2222_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	POLG SH2B1 PEX26 CFLAR SCARB2 SUGP1 LRP6	6.87e-05	197	116	7	1508_DN
Drug	Lidoflazine [3416-26-0]; Up 200; 8.2uM; PC3; HT_HG-U133A	PAPPA2 KRT32 CADM4 CCDC57 DIP2A LRP6 PML	6.87e-05	197	116	7	5804_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; PC3; HT_HG-U133A	BLMH CFLAR CCDC88C SUGP1 DOCK6 IL27RA PML	6.87e-05	197	116	7	7249_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A	EPPK1 POLG POLR3F CFLAR CCDC88C ZC3H7A SUGP1	6.87e-05	197	116	7	5044_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	SH2B1 ARRB1 DNAJA4 LRP6 PARD3 DOCK6 PBXIP1	6.87e-05	197	116	7	2484_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	ABCA2 ITPKB CFLAR CHMP7 EFNA1 AHNAK SUGP1	6.87e-05	197	116	7	1635_DN
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A	PAPPA2 CHST1 ITGB3 ITPR1 CCDC88C MTMR3 PML	7.09e-05	198	116	7	5457_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PAPPA2 PEX26 ITPKB CFLAR OLFML2A DNAJA4 LRP6	7.09e-05	198	116	7	4353_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; HL60; HG-U133A	PAPPA2 ABCA2 NPDC1 KRIT1 ITPR1 AHNAK SLC27A5	7.09e-05	198	116	7	2002_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	VWF FLVCR2 JAK3 OLFML2A IL1RAPL2 IL27RA PML	7.09e-05	198	116	7	2929_UP
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CDC42BPB PEX26 CFLAR CCDC88C DOCK6 PBXIP1 IL27RA	7.09e-05	198	116	7	1689_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A	PPP1R9A ITPKB ITPR1 BLMH SCARB2 SUGP1 LRP6	7.09e-05	198	116	7	6332_DN
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	KRIT1 ITPKB CFLAR ARRB1 DNAJA4 SUGP1 PML	7.09e-05	198	116	7	2274_DN
Drug	Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	ITGB3 ITPR1 CFLAR METTL1 IL1R2 LRP6 IL27RA	7.32e-05	199	116	7	7272_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	PPP1R9A SH2B1 PEX26 OLFML2A DNAJA4 LRP6 PML	7.32e-05	199	116	7	4765_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA	EPPK1 POLG PEX26 CFLAR SUGP1 N4BP2L2 TRMT13	7.32e-05	199	116	7	984_DN
Drug	Arecoline hydrobromide [300-08-3]; Down 200; 17uM; PC3; HT_HG-U133A	EPPK1 ITPR1 PASK IL1R2 SCG2 SCARB2 PML	7.32e-05	199	116	7	6322_DN
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	PAPPA2 ABCA2 POLG NPDC1 SH2B1 PEX26 POLD4	7.32e-05	199	116	7	578_UP
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	PAPPA2 CCDC88C OLFML2A IL1RAPL2 DNAJA4 SUGP1 PML	7.32e-05	199	116	7	1633_UP
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	AMPD2 KRIT1 CFLAR PASK SUGP1 TRMT13 IL27RA	7.55e-05	200	116	7	1682_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	PAPPA2 POLG SH2B1 OLFML2A DNAJA4 SUGP1 LRP6	7.55e-05	200	116	7	4364_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A	FLVCR2 CFLAR JAK3 ARRB1 DNAJA4 SCARB2 PBXIP1	7.55e-05	200	116	7	2348_UP
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A	REC8 KRT32 ITPR1 JAK3 OLFML2A SUGP1 PML	7.55e-05	200	116	7	4769_UP
Drug	glutamin	POLE POLG RBP3 DARS1 ITPR1 CFLAR DNAJA4 RRS1 IMMT PML	1.27e-04	461	116	10	CID000000738
Drug	pilosidine	TUB UBA7	1.53e-04	4	116	2	CID000637865
Drug	CBVMP	AMPD2 POLG	2.55e-04	5	116	2	CID000469585
Drug	C24:0	TUB PEX26 SCARB2 SLC27A5	2.67e-04	61	116	4	CID000011197
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CHST1 ITPR1 OLFML2A IL1R2 DNAJA4 PML	2.97e-04	177	116	6	4770_UP
Drug	NSC623156	AMPD2 POLG	3.81e-04	6	116	2	CID000360780
Drug	dFdCMP	POLE POLG	3.81e-04	6	116	2	CID000503015
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	POLG CFLAR DIP2A SCARB2 SUGP1 SLC27A5	4.09e-04	188	116	6	1865_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	POLG LAMP5 DARS1 CFLAR DIP2A IL1R2	4.09e-04	188	116	6	1421_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A	LAMP5 CFLAR SCARB2 SUGP1 LRP6 SLC27A5	4.21e-04	189	116	6	2928_DN
Drug	DABCO	UBA7 SCG2 TNXB	4.27e-04	29	116	3	CID000009237
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A	BLMH CFLAR IL1R2 SUGP1 PARD3 IL27RA	4.33e-04	190	116	6	1396_UP
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A	REC8 EPPK1 DNAH7 PASK SSH1 DNAJA4	4.33e-04	190	116	6	6156_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	PPP1R9A SH2B1 PEX26 ITPR1 SSH1 PML	4.33e-04	190	116	6	4362_DN
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PPP1R9A ITPR1 CFLAR DIP2A SUGP1 PARD3	4.45e-04	191	116	6	4969_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; HL60; HT_HG-U133A	DIP2A ARRB1 SUGP1 KIF17 IL27RA PML	4.45e-04	191	116	6	6149_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ABCA2 CCDC88C GAS2L1 SLC38A10 PARD3 IL27RA	4.45e-04	191	116	6	991_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; HL60; HG-U133A	PAPPA2 LAMP5 BLMH METTL1 N4BP2L2 TRMT13	4.45e-04	191	116	6	1613_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	METTL1 DIP2A IL1R2 SUGP1 ENDOG NOP2	4.58e-04	192	116	6	1153_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	POLG PEX26 ITPR1 OLFML2A IL1RAPL2 DNAJA4	4.58e-04	192	116	6	3375_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	PAPPA2 KRIT1 ITPR1 OLFML2A AHNAK PBXIP1	4.58e-04	192	116	6	2123_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	PAPPA2 EPPK1 ITPKB CFLAR DIP2A ARRB1	4.70e-04	193	116	6	3258_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	PAPPA2 CFLAR ARRB1 SUGP1 DOCK6 IL27RA	4.70e-04	193	116	6	3906_DN
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A	PAPPA2 PPP1R9A OLFML2A DNAJA4 SUGP1 PML	4.70e-04	193	116	6	4788_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PEX26 ITPR1 OLFML2A PBXIP1 IL27RA PML	4.70e-04	193	116	6	5271_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A	PAPPA2 ITPR1 CFLAR DNAJA4 AHNAK DOCK6	4.70e-04	193	116	6	4208_UP
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	FLVCR2 PASK SCARB2 SUGP1 IL27RA PML	4.70e-04	193	116	6	2079_UP
Drug	AC1Q6S3R	POLE POLG POLD4 REV1	4.78e-04	71	116	4	CID000000625
Drug	Dale	PAPPA2 TUB IL1RAPL2 IL1R2	4.78e-04	71	116	4	CID005486816
Drug	ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A	CFLAR DIP2A SUGP1 PBXIP1 SLC27A5 PML	4.83e-04	194	116	6	6165_DN
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	KRIT1 ITPR1 JAK3 PASK SUGP1 DOCK6	4.83e-04	194	116	6	898_UP
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	FRMPD4 POLG CHST1 CCDC57 DNAJA4 MTMR3	4.83e-04	194	116	6	4552_UP
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	EPPK1 SH2B1 CFLAR OLFML2A UBA7 PML	4.83e-04	194	116	6	1628_UP
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	EPPK1 POLG NPDC1 ITPR1 CFLAR PML	4.83e-04	194	116	6	2087_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; HL60; HT_HG-U133A	FLVCR2 CCDC57 PRX JAK3 PBXIP1 PML	4.83e-04	194	116	6	2391_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A	CCDC88C SCARB2 LRP6 PARD3 SLC27A5 PML	4.83e-04	194	116	6	2434_DN
Drug	Avermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A	CADM4 CHST1 ITPR1 CFLAR PBXIP1 PML	4.83e-04	194	116	6	6081_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PAPPA2 ABCA2 ITPR1 OLFML2A SUGP1 PML	4.83e-04	194	116	6	3625_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ABCA2 CFLAR SUGP1 LRP6 PARD3 DOCK6	4.83e-04	194	116	6	4107_DN
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	PASK MTMR3 SUGP1 POLD4 TRMT13 PML	4.97e-04	195	116	6	7434_UP
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A	REC8 PAPPA2 ABCA2 DNAJA4 AHNAK MTMR3	4.97e-04	195	116	6	6159_UP
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ITPR1 CFLAR UBA7 DNAJA4 LRP6 PML	4.97e-04	195	116	6	5468_UP
Drug	Bethanechol chloride [590-63-6]; Up 200; 20.4uM; HL60; HT_HG-U133A	GALNT10 CFLAR AHNAK PARD3 DOCK6 PML	4.97e-04	195	116	6	2975_UP
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A	PAPPA2 CCDC88C OLFML2A GAS2L1 DOCK6 PML	4.97e-04	195	116	6	4696_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A	ABCA2 CCDC57 PASK SCARB2 LRP6 PML	4.97e-04	195	116	6	2740_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	REC8 PEX26 PASK SUGP1 IL27RA PML	4.97e-04	195	116	6	1857_UP
Drug	monastrol; Up 200; 100uM; MCF7; HG-U133A	GALNT10 SH2B1 ITPKB OLFML2A ARRB1 LRP6	4.97e-04	195	116	6	311_UP
Disease	Nasal Type Extranodal NK/T-Cell Lymphoma	CFLAR JAK3	4.27e-05	3	112	2	C0392788
Disease	Lymphoma, Extranodal NK-T-Cell	CFLAR JAK3	4.27e-05	3	112	2	C1955906
Disease	Pituitary-dependent Cushing's disease	CDH23 AIP	1.42e-04	5	112	2	C0221406
Disease	Prolactinoma	CDH23 AIP	2.12e-04	6	112	2	C0033375
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPB KRIT1	7.68e-04	11	112	2	DOID:0060669 (implicated_via_orthology)
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK7 DOCK6	1.08e-03	13	112	2	OBA_2045159
Disease	Pneumoconiosis	CDH23 IL27RA	1.26e-03	14	112	2	C0032273
Disease	Bagassosis	CDH23 IL27RA	1.26e-03	14	112	2	C0004681
Disease	N-acetylmethionine measurement	CHST1 ITPR1	1.45e-03	15	112	2	EFO_0021427
Disease	anemia (implicated_via_orthology)	SLC4A2 SLC4A10	1.45e-03	15	112	2	DOID:2355 (implicated_via_orthology)
Disease	sex interaction measurement, ulcerative colitis	SH2B1 TNXB	1.87e-03	17	112	2	EFO_0000729, EFO_0008343
Disease	Malignant neoplasm of endometrium	POLE RAD21	2.10e-03	18	112	2	C0007103
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK7 DOCK6	2.10e-03	18	112	2	OBA_2045155
Disease	Carcinoma in situ of endometrium	POLE RAD21	2.10e-03	18	112	2	C0346191
Disease	dentures	ITPKB MTMR3 MAMSTR	2.42e-03	70	112	3	EFO_0010078
Disease	dental caries, dentures	ITPKB MTMR3 MAMSTR	2.42e-03	70	112	3	EFO_0003819, EFO_0010078
Disease	waist-hip ratio	PAPPA2 CCDC12 ITGB3 SH2B1 CFAP65 OLFML2A SSC5D EFNA1 AHNAK MINDY4 DOCK6 PML	2.42e-03	1226	112	12	EFO_0004343
Disease	myelodysplastic syndrome (is_marker_for)	ITGB3 CFLAR	2.59e-03	20	112	2	DOID:0050908 (is_marker_for)
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	DOCK7 DOCK6	2.86e-03	21	112	2	OBA_2045156
Disease	level of Phosphatidylinositol (18:0_20:4) in blood serum	DOCK7 DOCK6	3.43e-03	23	112	2	OBA_2045158

Protein segments in the cluster

Peptide	Gene	Start	Entry
VELDAVLEVPVPVRF	SLC4A2	541	P04920
ERVANREENEILPPD	SDF4	46	Q9BRK5
AEEVEERAPAQNPEL	BAG6	236	P46379
RETPQGELRPEVVED	SH3BP5L	11	Q7L8J4
EGVELNDRAIPPEDL	CFAP46	671	Q8IYW2
EVKELQREPLTPEEV	CIAPIN1	126	Q6FI81
EVDIRGPQVDIDVPD	AHNAK	2996	Q09666
PQPRDEEEAELELLR	POLD4	36	Q9HCU8
QEPELEPGDVIIVLD	DNAJA4	231	Q8WW22
EFPEESPIEQLEERR	AMPD2	146	Q01433
ALEDIDDNEPLFVRP	CDH23	2711	Q9H251
EVRVVLEDINDQPPR	CDH23	2831	Q9H251
RDVAIDVVPPNVRDL	CFLAR	26	O15519
IDLVDPVDGVVLVDP	ARRB1	31	P49407
VLELDPALAPVVSRE	AIP	291	O00170
AEEEEAILLEIPRLP	REC8	226	O95072
LVPNEEEAFALEPID	RAD21	296	O60216
QRDVIDEPIIEEPSR	RAD21	436	O60216
KEVAPPRLLEEVAEQ	JAK3	361	P52333
VLAAEPRLLVPVDVD	ANAPC1	1611	Q9H1A4
REEPVAIESPGQDLL	PASK	516	Q96RG2
VPQEEEEEVRVLTLP	ADIPOR1	56	Q96A54
DDRNEPVLRLDNAPE	MUC15	276	Q8N387
PPVLLEDELREEVTV	FSCB	226	Q5H9T9
AIVPVSPAEVRDLDF	ITPR1	431	Q14643
ILEVDRLPNETAVPE	ITPR1	2476	Q14643
RSPPELVAEIVLVDD	GALNT10	171	Q86SR1
PFRIEISPDELAEDQ	CFAP65	391	Q6ZU64
IEVDAAPPVDLTRVL	KRT32	251	Q14532
ELEDIEPDRNLPVGL	LMOD2	36	Q6P5Q4
ELPDVAPEELEALSR	CCDC88C	176	Q9P219
RAVPARAPAVDLLEE	PEX26	26	Q7Z412
EGEAVPVAIPEERAL	POLG	181	P54098
PVAIPEERALVFDVE	POLG	186	P54098
EAQPLGDLPILEVEE	IL27RA	576	Q6UWB1
PPADIGDLREQLVEE	PI4KAP1	171	Q8N8J0
ISEDLEEPRAIVLDP	LRP6	441	O75581
ERPPEEVAARLAQQE	IMMT	196	Q16891
PVDEREQLEETLPLI	LAMP5	226	Q9UJQ1
DVRLPLEVEKQIEDP	KRIT1	511	O00522
NVEVDAAPPVDLNRV	KRT35	251	Q92764
DDLVERPDPVVLAFD	POLE	261	Q07864
DVDDDVLRNTEILPP	CDC42BPB	371	Q9Y5S2
DILEPPEVAAARESI	KIF19	501	Q2TAC6
PQPRLEDEIDFLAQE	NPDC1	91	Q9NQX5
PEVLAEIPREAFTVE	PAPPA2	276	Q9BXP8
PLEVAQVFLAEIPED	DOCK6	1946	Q96HP0
LRDLIEFPPDDIEVV	DOCK7	76	Q96N67
LLSEQRPVDIPEDEL	CABP7	21	Q86V35
PQEKRLAADDPEVRV	EFNA1	161	P20827
VPNPRISDAELEAEL	CHMP7	411	Q8WUX9
EQEIERELRAAPPAP	GAS2L1	161	Q99501
EPVSAAPRERVIDLV	FRMPD4	126	Q14CM0
LENVGEELDPILEPL	DNAH7	3036	Q8WXX0
LVAPENPVVEVREQA	CADM4	121	Q8NFZ8
PTELRALVADEPEDL	ABCA2	2396	Q9BZC7
DELDEVNPRLREPQE	AGBL2	151	Q5U5Z8
LEPAALQRELPREVD	CCDC57	686	Q2TAC2
PLVAPEDLRDDIIEN	PRMT5	156	O14744
EEVLAVLEQEPIILP	BLMH	431	Q13867
LVPPVLVPNIEDRDE	FLVCR2	231	Q9UPI3
PEPGELEERFAIVLN	FMNL2	26	Q96PY5
PNRGIDDILEDQVEP	MAMSTR	306	Q6ZN01
TLAPPRRDVAVAEEV	FBLIM1	16	Q8WUP2
EFPVSEARVLEDRPL	ITGB3	81	P05106
EPVIEEVDLANLAPR	CCDC12	96	Q8WUD4
APLPAEVRESLAELE	DIP2A	11	Q14689
GLDAEPELSPEEQRV	C7orf50	51	Q9BRJ6
DAAVQEPRQRPEPEL	SLC38A10	1006	Q9HBR0
QPPDAREEDIILEGQ	FAM171B	596	Q6P995
KPDEVRLENPVDVVD	HELB	406	Q8NG08
IAEGREEAVLPIPVD	MTMR3	801	Q13615
DEAQPEVIVLSRLDP	OLFML2A	541	Q68BL7
DDTVIIEDDRLPVLP	PARD3	756	Q8TEW0
PRPEVDLASEVALEV	KIF17	671	Q9P2E2
VELVPVVELEEAIAP	SH2B1	696	Q9NRF2
AGLRDETEIPEQLVP	TRMT13	96	Q9NUP7
PEEEQFALEVLPDVL	IL1RAPL2	421	Q9NP60
RELEDLQPPEALVER	ITPKB	331	P27987
NAPVDEAIPLERFLV	ENDOG	251	Q14249
RDPIDVDLPEEAERV	PML	411	P29590
EVIAGPERENDVPLV	GPRASP2	21	Q96D09
IIEEAEEAPGARPQL	EPPK1	3641	P58107
IIEEAEEAPGARPQL	EPPK1	4711	P58107
NGSVEPERELDLPVD	SCG2	376	P13521
QRIVEDAPPIDLQAE	POLR2B	56	P30876
NPEEILRGETPRVEE	SCARB2	71	Q14108
VLPEVEPGLTAREQE	SDC1	106	P18827
PDADPVEIENRIIEL	POLR3F	11	Q9H1D9
RLPLQLDDAVRPEAE	DARS1	151	P14868
EPPALVELVAAVRDV	SSC5D	1486	A1L4H1
ELVEFLEANEVPRPV	NOP2	296	P46087
PAEREEDAGIIVLAP	ABCC12	726	Q96J65
IEVPLIFDPVTREDL	IL1R2	306	P27930
EREALLEEAAPPAEV	SSH1	536	Q8WYL5
AADQEVPRDAVLPEQ	EIF4ENIF1	286	Q9NRA8
PEVNDLRALVEDPRL	CHST1	211	O43916
EDKVELPPAELVQRD	SUGP1	391	Q8IWZ8
LEPDRPEVFEQRAEI	TTC13	211	Q8NBP0
VAPELPEDEAIRQAL	RBP3	411	P10745
IQDFETLPREAPDLV	VWF	1651	P04275
EDELIREEVILSPVP	MINDY4	381	Q4G0A6
EEVERQVLPDPEVLE	PBXIP1	226	Q96AQ6
QVLPDPEVLEAVGDR	PBXIP1	231	Q96AQ6
VDPEVFAALPAELQR	REV1	1016	Q9UBZ9
PLEEPLDEALVRTVA	UBA7	336	P41226
VVDPDLRESLEEILP	SLC27A5	226	Q9Y2P5
IEEGEIVQPEEEPRL	SCAF1	391	Q9H7N4
PLAEREPGEVIDSLV	SPIN3	196	Q5JUX0
TERVEEAIVARLPEP	RRS1	81	Q15050
PEAALPEVRLPEVEL	PRX	456	Q9BXM0
SRPLALPLVEEEEAV	RNF10	441	Q8N5U6
EPLLPTRNDEEAVVD	SLC4A10	11	Q6U841
VPVAADQREVTIPDL	TNXB	1621	P22105
LLEAPEPDVEAELSR	TMDD1	51	P0DPE3
RLLEAVAATAAEEPP	SH2B2	601	O14492
VEDIEPDLLTPRQEA	ZC3H7A	201	Q8IWR0
PDEDISLEERRAQLP	ZNF207	366	O43670
VEEPITVEVAFRNPL	TRAPPC8	751	Q9Y2L5
VEVQDLEEFALRPAP	TUB	246	P50607
LFERVPLEDLSEDPV	METTL1	216	Q9UBP6
PDPQDLEERDILRVT	ZNF641	171	Q96N77
VLQEARPPLVSADDE	N4BP2L2	101	Q92802
EIVGLPEEEEIPANR	PPP1R9A	441	Q9ULJ8